FI105074B - Farmaseuttisen formulaation valmistusmenetelmä - Google Patents

Farmaseuttisen formulaation valmistusmenetelmä Download PDF

Info

Publication number
FI105074B
FI105074B FI974664A FI974664A FI105074B FI 105074 B FI105074 B FI 105074B FI 974664 A FI974664 A FI 974664A FI 974664 A FI974664 A FI 974664A FI 105074 B FI105074 B FI 105074B
Authority
FI
Finland
Prior art keywords
suspension
process according
particles
drug
active ingredient
Prior art date
Application number
FI974664A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI974664A0 (fi
FI974664A (fi
Inventor
Tapio Lankinen
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of FI974664A0 publication Critical patent/FI974664A0/fi
Priority to FI974664A priority Critical patent/FI105074B/fi
Priority to RU2000120196/14A priority patent/RU2203045C2/ru
Priority to PL98341410A priority patent/PL341410A1/xx
Priority to US09/582,370 priority patent/US6616945B1/en
Priority to EEP2000004010A priority patent/EE04993B1/xx
Priority to KR1020007007248A priority patent/KR20010033725A/ko
Priority to DE1041971T priority patent/DE1041971T1/de
Priority to IL13701798A priority patent/IL137017A0/xx
Priority to NZ505400A priority patent/NZ505400A/xx
Priority to CA002314112A priority patent/CA2314112C/en
Priority to JP2000527229A priority patent/JP4131610B2/ja
Priority to PCT/FI1998/001001 priority patent/WO1999034778A1/en
Priority to EP98962441A priority patent/EP1041971A1/en
Priority to CNB988126222A priority patent/CN1172659C/zh
Priority to AU17608/99A priority patent/AU754074B2/en
Priority to HU0100398A priority patent/HUP0100398A2/hu
Publication of FI974664A publication Critical patent/FI974664A/fi
Application granted granted Critical
Publication of FI105074B publication Critical patent/FI105074B/fi
Priority to NO20003393A priority patent/NO20003393L/no
Priority to JP2007264197A priority patent/JP2008019279A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
FI974664A 1997-12-31 1997-12-31 Farmaseuttisen formulaation valmistusmenetelmä FI105074B (fi)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FI974664A FI105074B (fi) 1997-12-31 1997-12-31 Farmaseuttisen formulaation valmistusmenetelmä
NZ505400A NZ505400A (en) 1997-12-31 1998-12-21 A method for making a homogeneous powdered pharmaceutical formulation by suspending particles in suspending agent, then evaporating suspending agent
JP2000527229A JP4131610B2 (ja) 1997-12-31 1998-12-21 医薬製剤の製造方法
US09/582,370 US6616945B1 (en) 1997-12-31 1998-12-21 Method for making a pharmaceutical formulation
EEP2000004010A EE04993B1 (et) 1997-12-31 1998-12-21 Inhalatsioonipulbri valmistamismeetod
KR1020007007248A KR20010033725A (ko) 1997-12-31 1998-12-21 약제학적 제형의 제조방법
DE1041971T DE1041971T1 (de) 1997-12-31 1998-12-21 Eine methode zur herstellung einer pharmazeutischen zusammensetzung
IL13701798A IL137017A0 (en) 1997-12-31 1998-12-21 A method for making a pharmaceutical formulation
RU2000120196/14A RU2203045C2 (ru) 1997-12-31 1998-12-21 Способ получения фармацевтического состава
CA002314112A CA2314112C (en) 1997-12-31 1998-12-21 A method for making a pharmaceutical formulation
PL98341410A PL341410A1 (en) 1997-12-31 1998-12-21 Method of obtaining a pharmacological composition
PCT/FI1998/001001 WO1999034778A1 (en) 1997-12-31 1998-12-21 A method for making a pharmaceutical formulation
EP98962441A EP1041971A1 (en) 1997-12-31 1998-12-21 A method for making a pharmaceutical formulation
CNB988126222A CN1172659C (zh) 1997-12-31 1998-12-21 一种药物制剂的制备方法
AU17608/99A AU754074B2 (en) 1997-12-31 1998-12-21 A method for making a pharmaceutical formulation
HU0100398A HUP0100398A2 (hu) 1997-12-31 1998-12-21 Eljárás gyógyászati készítmény előállítására
NO20003393A NO20003393L (no) 1997-12-31 2000-06-29 FremgangsmÕte for fremstilling av en farmasøytisk formulering
JP2007264197A JP2008019279A (ja) 1997-12-31 2007-10-10 医薬製剤の製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI974664A FI105074B (fi) 1997-12-31 1997-12-31 Farmaseuttisen formulaation valmistusmenetelmä
FI974664 1997-12-31

Publications (3)

Publication Number Publication Date
FI974664A0 FI974664A0 (fi) 1997-12-31
FI974664A FI974664A (fi) 1999-07-01
FI105074B true FI105074B (fi) 2000-06-15

Family

ID=8550254

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974664A FI105074B (fi) 1997-12-31 1997-12-31 Farmaseuttisen formulaation valmistusmenetelmä

Country Status (17)

Country Link
US (1) US6616945B1 (no)
EP (1) EP1041971A1 (no)
JP (2) JP4131610B2 (no)
KR (1) KR20010033725A (no)
CN (1) CN1172659C (no)
AU (1) AU754074B2 (no)
CA (1) CA2314112C (no)
DE (1) DE1041971T1 (no)
EE (1) EE04993B1 (no)
FI (1) FI105074B (no)
HU (1) HUP0100398A2 (no)
IL (1) IL137017A0 (no)
NO (1) NO20003393L (no)
NZ (1) NZ505400A (no)
PL (1) PL341410A1 (no)
RU (1) RU2203045C2 (no)
WO (1) WO1999034778A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI116657B (fi) * 2002-03-28 2006-01-31 Focus Inhalation Oy Menetelmä kantoainehiukkasten käsittelemiseksi ja niiden käyttö
WO2003084509A1 (en) * 2002-04-04 2003-10-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations suitable for inhalation
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2009046215A2 (en) * 2007-10-02 2009-04-09 Lab International Srl Safety and abuse deterrent improved device
JP5893616B2 (ja) 2010-10-18 2016-03-23 大日本住友製薬株式会社 注射用徐放性製剤
CN110025578B (zh) * 2019-04-10 2021-06-15 深圳市新阳唯康科技有限公司 一种治疗哮喘类肺部疾病的共无定形粉末及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB937303A (en) 1959-01-02 1963-09-18 Benger Lab Ltd Improvements in and relating to the application of drugs in finely divided condition
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
WO1990013327A1 (en) 1989-04-28 1990-11-15 Riker Laboratories, Inc. Dry powder inhalation device
SE9101090D0 (sv) 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5191114A (en) * 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
US5393716A (en) * 1992-09-25 1995-02-28 Ecc International Limited Process for producing anti-blocking compositions
US5503869A (en) 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
GB9610821D0 (en) * 1996-05-23 1996-07-31 Glaxo Wellcome Inc Metering apparatus

Also Published As

Publication number Publication date
EP1041971A1 (en) 2000-10-11
CA2314112C (en) 2008-06-17
EE200000401A (et) 2001-10-15
WO1999034778A1 (en) 1999-07-15
NO20003393L (no) 2000-07-31
PL341410A1 (en) 2001-04-09
JP2008019279A (ja) 2008-01-31
FI974664A0 (fi) 1997-12-31
JP4131610B2 (ja) 2008-08-13
HUP0100398A2 (hu) 2001-08-28
NZ505400A (en) 2003-06-30
DE1041971T1 (de) 2001-02-08
RU2203045C2 (ru) 2003-04-27
CN1172659C (zh) 2004-10-27
CN1283109A (zh) 2001-02-07
KR20010033725A (ko) 2001-04-25
NO20003393D0 (no) 2000-06-29
AU1760899A (en) 1999-07-26
US6616945B1 (en) 2003-09-09
IL137017A0 (en) 2001-06-14
CA2314112A1 (en) 1999-07-15
EE04993B1 (et) 2008-04-15
JP2002500176A (ja) 2002-01-08
FI974664A (fi) 1999-07-01
AU754074B2 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
US6153224A (en) Carrier particles for use in dry powder inhalers
KR100951750B1 (ko) 분무 건조 방법 및 그 조성물
US20100092453A1 (en) Method of producing porous microparticles
MX2008012794A (es) Microparticulas de farmacos.
SK12482001A3 (sk) Prášok na použitie v inhalátore na suché prášky, nosič na tento prášok a spôsob výroby prášku
PL199420B1 (pl) Medyczne preparaty aerozolowe
Saboti et al. Novel budesonide particles for dry powder inhalation prepared using a microfluidic reactor coupled with ultrasonic spray freeze drying
JP2008019279A (ja) 医薬製剤の製造方法
DK1496857T3 (en) AEROSOL CONTAINING A PARTICULAR ACTIVE CONNECTION
Westmeier et al. Combination particles containing salmeterol xinafoate and fluticasone propionate: Formulation and aerodynamic assessment
CN107205936A (zh) 包含至少一种通过喷雾干燥得到的增加制剂稳定性的干粉的组合物
FI116657B (fi) Menetelmä kantoainehiukkasten käsittelemiseksi ja niiden käyttö
JP2000512268A (ja) 吸入用微粒子含有配合物
Gilani et al. Influence of formulation variables and inhalation device on the deposition profiles of cromolyn sodium dry powder aerosols
CN110740724A (zh) 无定形的纳米结构药物材料
MXPA00006458A (en) A method for making a pharmaceutical formulation
Hadi Spray Drying of Cocrystals for Engineering Particle Properties: Diploma Work
CN107205958A (zh) 包含福莫特罗和布地奈德的药物组合物

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: LAB PHARMA OY

Free format text: LAB PHARMA OY